Literature DB >> 7614452

Gelsolin: a candidate for suppressor of human bladder cancer.

M Tanaka1, L Müllauer, Y Ogiso, H Fujita, S Moriya, K Furuuchi, T Harabayashi, N Shinohara, T Koyanagi, N Kuzumaki.   

Abstract

Human transitional cell carcinomas of the bladder frequently reveal chromosomal abnormalities that span a range between chromosome 9p12 and 9qter, even at early stages of bladder carcinogenesis. Because the gene that encodes an actin-regulatory protein, gelsolin, is localized in chromosome 9q33, we examined the expression of gelsolin in a number of human bladder cancer cell lines and tissues. In all 6 cell lines and in 14 of the 18 tumor tissues (77.8%), gelsolin expression was undetectable or extremely low in comparison with its expression in normal bladder epithelial cells. Furthermore, upon the introduction of the exogenous human or mouse authentic gelsolin cDNA into a human bladder cancer cell line, UMUC-2, gelsolin transfectants of UMUC-2 greatly reduced the colony-forming ability and the tumorigenicity in vivo. These results suggest that gelsolin plays a key role as a tumor suppressor in human urinary bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614452

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling.

Authors:  Veerle De Corte; Erik Bruyneel; Ciska Boucherie; Marc Mareel; Joël Vandekerckhove; Jan Gettemans
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

2.  The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.

Authors:  Kohei Hashimoto; Yuki Kyoda; Toshiaki Tanaka; Toshihiro Maeda; Ko Kobayashi; Kohsuke Uchida; Hiroshi Kitamura; Koichi Hirata; Taiji Tsukamoto; Naoya Masumori
Journal:  Lab Invest       Date:  2015-01-12       Impact factor: 5.662

3.  A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.

Authors:  A Saito; T Yamashita; Y Mariko; Y Nosaka; K Tsuchiya; T Ando; T Suzuki; T Tsuruo; O Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

Authors:  H Onda; A Lueck; P W Marks; H B Warren; D J Kwiatkowski
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 5.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

6.  Gelsolin regulates proliferation, apoptosis, migration and invasion in human oral carcinoma cells.

Authors:  Runzhi Deng; Jing Hao; Wei Han; Yanhong Ni; Xiaofeng Huang; Qingang Hu
Journal:  Oncol Lett       Date:  2015-03-02       Impact factor: 2.967

Review 7.  Metastasis suppressors and the tumor microenvironment.

Authors:  Leah M Cook; Douglas R Hurst; Danny R Welch
Journal:  Semin Cancer Biol       Date:  2010-12-17       Impact factor: 15.707

8.  Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression.

Authors:  Marta Sanchez-Carbayo; Nicholas D Socci; Lee Richstone; Marta Corton; Nille Behrendt; Julia Wulkfuhle; Bernard Bochner; Emmanuel Petricoin; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

9.  The ubiquitin-proteasome pathway mediates gelsolin protein downregulation in pancreatic cancer.

Authors:  Xiao-Guang Ni; Lu Zhou; Gui-Qi Wang; Shang-Mei Liu; Xiao-Feng Bai; Fang Liu; Maikel P Peppelenbosch; Ping Zhao
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

Review 10.  [Non-invasive urinary diagnosis of bladder cancer. What do we know?].

Authors:  I Kausch; A Böhle
Journal:  Urologe A       Date:  2003-04-11       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.